Crossmark

Development and validation of a succinylation-related prognostic model for esophageal squamous cell carcinoma based on multi-omics bioinformatics analysis

Crossref DOI link: https://doi.org/10.1186/s41065-026-00653-2

Published Online: 2026-02-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hua, Beibei

Wang, Weiwei

Huang, Huijie

Chang, Xuezhi

Ye, Tao
Funding

Funding for this research was provided by:

the State Key Lab of Pathogenesis,Prevention and Treatment of High Incidence Diseases in Central Asia Fund (SKL-HIDCA-2024-YY15)

Ili & Jiangsu Joint Institute of Health (yl2022py16)
License Information

Text and Data Mining valid from 2026-02-17

Version of Record valid from 2026-03-25
More Information

Article History

Received: 25 October 2025

Accepted: 8 February 2026

First Online: 17 February 2026

Declarations

:

: The majority of this study utilized publicly available data from TCGA and GEO databases, which are compliant with all applicable ethical guidelines.

: All patients provided informed consent, and the study was conducted in accordance with the principles outlined in the Declaration of Helsinki.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below